TOWER sales quadruple

TOWER sales quadruple

TOWER's solution to covering non-Pharmac funded cancer drugs has hit the mark with advisers, with sales of the trauma add-on option to its health insurance quadrupling since key enhancements were introduced in August this year.

 



1 min read
1 min read
1 min read
BNZ out alone